Fig. 1From: The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trialsKaplan-Meier plots of primary end point achievement in placebo-treated USA and outside USA populations. CI confidence interval, HR hazard ratioBack to article page